Plain-English translation of NCT06945406 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 1 research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a new medication called LY4057996 to see how well it is tolerated and what side effects it might cause in healthy people and people with type 1 or type 2 diabetes. The medication will be given either as an injection under the skin or through an IV line in your arm. Blood tests will measure how much of the medication gets into your bloodstream and how quickly your body clears it.
Researchers are exploring new treatment options for diabetes and need to understand if this medication is safe before testing it more broadly in patients. Early safety studies like this one are essential steps to determine whether a new treatment can move forward to larger clinical trials.
You likely qualify if…
You likely don't qualify if…
Your participation will last between 4 to 11 weeks depending on which part of the study you join, plus an initial screening period. You will receive either the new medication or a placebo (a dummy treatment with no active ingredient) by injection under the skin or through an IV line. Throughout the study, you'll have multiple blood tests to check how your body is handling the medication, and the research team will monitor you closely for any side effects or safety concerns.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Germany